Literature DB >> 12771472

A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma.

Chang-Hun Huh1, Koo-Il Seo, Je-Young Park, Jeong-Gu Lim, Hee-Chul Eun, Kyung-Chan Park.   

Abstract

BACKGROUND: Vitamin C is known to both inhibit melanin formation and reduce oxidized melanin. However, vitamin C does not easily penetrate the skin. In this study, vitamin C iontophoresis was employed in order to enhance vitamin C penetration.
OBJECTIVE: The purpose of this study was to evaluate the efficacy of vitamin C iontophoresis for melasma patients.
METHODS: Twenty-nine females with melasma were enrolled. For iontophoresis, a vitamin C solution was applied to one side of the face, while distilled water was applied to the other side as a control. The L (luminance) value was measured by a colorimeter to obtain an objective pigmentation parameter.
RESULTS: Twelve weeks after iontophoresis, the colorimeter of the treated site showed a significant decrease in the L value (from 4.60 to 2.78, p = 0.002), compared to that of the control site (from 4.45 to 3.87, p = 0.142).
CONCLUSION: Vitamin C iontophoresis may be an effective treatment modality for melasma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771472     DOI: 10.1159/000069943

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

Review 1.  Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review.

Authors:  Jasmine C Hollinger; Kunal Angra; Rebat M Halder
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

2.  In vitro extraction of intra-corneal iron using reverse iontophoresis and vitamin C.

Authors:  Jian-Hai Bai; Sheng Su; Lei Huang; Yan-Yan Zhang; Yun-Song Wang; Mei-Hua Guo; Hong-Bin Yang; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-05       Impact factor: 3.117

3.  Evidence-based treatment for melasma: expert opinion and a review.

Authors:  Krupa Shankar; Kiran Godse; Sanjeev Aurangabadkar; Koushik Lahiri; Venkat Mysore; Anil Ganjoo; Maya Vedamurty; Malavika Kohli; Jaishree Sharad; Ganesh Kadhe; Pashmina Ahirrao; Varsha Narayanan; Salman Abdulrehman Motlekar
Journal:  Dermatol Ther (Heidelb)       Date:  2014-10-01

4.  Evaluation of the Anti-Inflammatory Effect of Locally Delivered Vitamin C in the Treatment of Persistent Gingival Inflammation: Clinical and Histopathological Study.

Authors:  Nermin M Yussif; Manar A Abdul Aziz; Ahmed R Abdel Rahman
Journal:  J Nutr Metab       Date:  2016-12-05

5.  Evidence-based Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma.

Authors:  Nilendu Sarma; Sayantani Chakraborty; Shital A Poojary; Sanjay Rathi; Sendhil Kumaran; Balakrishnan Nirmal; Joan Felicita; Rashmi Sarkar; Prashansa Jaiswal; Paschal D'Souza; Nagaraju Donthula; Sumit Sethi; Pallavi Ailawadi; Bebisha Joseph
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec

Review 6.  Neural Stem Cells and Its Derivatives as a New Material for Melanin Inhibition.

Authors:  Insik Hwang; Sunghoi Hong
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

Review 7.  The effect of Vitamin C on melanin pigmentation - A systematic review.

Authors:  Rizwan M Sanadi; Revati S Deshmukh
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

Review 8.  Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.

Authors:  Zuzanna Piętowska; Danuta Nowicka; Jacek C Szepietowski
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

9.  Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.

Authors:  Georgia Siow Kiang Lee
Journal:  J Cosmet Laser Ther       Date:  2008-12       Impact factor: 2.247

10.  Inhibition of melanogenesis by sodium 2-mercaptoethanesulfonate.

Authors:  Jeong-Hwan Kim; Chang-Taek Oh; Tae-Rin Kwon; Jong Hwan Kim; Dong-Ho Bak; Hyuk Kim; Won-Seok Park; Beom Joon Kim
Journal:  Korean J Physiol Pharmacol       Date:  2020-02-20       Impact factor: 2.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.